News & Updates

The third-generation human epidermal growth factor receptor 2 (HER2)-directed antibody‒drug conjugate (ADC) SHR-A1811 has passed its phase II trial, demonstrating safety and efficacy in the neoadjuvant setting for patients with HER2-positive breast cancer.

Researchers from Singapore found an elevated risk of venous thromboembolism (VTE) events in individuals with Parkinson’s disease (PD) in a systematic review and meta-analysis of 13 studies.

Individuals with borderline diabetes may benefit from drinking mulberry leaves and water chestnut husk (MW) tea, which has been shown in a Japan study to reduce insulin secretion and prevent spikes in blood glucose levels.

Pregnant women with high adherence to the Dietary Approaches to Stop Hypertension (DASH) diet have a much lower chance of having large-for-gestational-age (LGA) newborns, reports a Brazil study.